ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 111533 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 111533; 2) Community: the network communities that were significantly associated with the response to NSC 111533; 3) Molecule: the relationships between components within communities and NSC 111533; 4) MDR: the compounds that were significantly associated with the NSC 111533.

NSC Compound Enrichment Correlation
NSC 633271 Null 0.0209467683758282 -0.017116323
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0209467683758282 0.075210294
NSC 661832 Null 0.0209467683758282 0.084056545
NSC 665522 Null 0.0209467683758282 0.1527401
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0209467683758286 0.31018974
NSC 603071 Aminocamptothecin 0.0209467683758286 0.83621666
NSC 615291 Bizelesin 0.0209467683758286 0.66978025
NSC 615534 Null 0.0209467683758286 0.25544063
NSC 673652 2-Ethylaminoestradiol 0.0209467683758286 0.19112031
NSC 681641 Camptothecin Derivative 0.0209467683758286 0.77547092
Total:56  Current:24    [First] [Prev] [Next] [Last]